Patent · US Expired

N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives

US5028608A · kind A · utility

37Cited by
26References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 1990
Grant dateJul 2, 1991
Priority date
Expiry dateMay 24, 2010

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

N-(Acyl)glutamic acid derivatives in which the acyl group is substituted with 4-hydroxypyrrolo[2,3-d]-pyrimidin-3-yl group are antineoplastic agents. A typical embodiment is N-{5-[2-(4-hydroxy-6-aminopyrrolo[2,3-d]pyrimidin-3-yl)ethyl]thien-2-ylcar bonyl}-L-glutamic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.